Company

Cordlife Group Ltd

Headquarters: Singapore, Singapore

CEO: Ms. Poh Lan Tan

SGX: P8A +5.41%

Market Cap

S$36.7 Million

SGD as of July 1, 2024

US$27.0 Million

Market Cap History

Cordlife Group Ltd market capitalization over time

Evolution of Cordlife Group Ltd market cap in the past 5 years

Market capitalizations are calculated from the opening stock price at the beginning of each month.

Market Cap History of Cordlife Group Ltd

Detailed Description

Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It provides cord blood, cord lining, and cord tissue banking services comprising processing and storage of stem cells; and non-invasive prenatal testing, paediatric vision screening, newborn metabolic screening, and newborn genetic screening services. The company also offers preimplantation genetic screening, endometrial receptivity test, paediatric allergen test, and genetic talent test services, as well as moms up, a mobile app for pregnancy and parenting resources. In addition, it provides management, marketing, and property investment services. The company was formerly known as Cordlife Pte Ltd and changed its name to Cordlife Group Limited in 2011. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore.

Top 1-year algo backtest: +265.99%

$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.

Use AI to boost your investing & swing trading, now!

Try Disfold DeepFinance FREE

Stocks & Indices

Cordlife Group Ltd has the following listings and related stock indices.


Stock: SGX: P8A wb_incandescent

Stock: XSTU: 3DC wb_incandescent

Stock: OTC: CLIFF wb_incandescent

Details

Headquarters:

A’Posh Bizhub

No. 06-01/09, 1 Yishun Ind. Street 1

Singapore, 768160

Singapore

Phone: 65 6238 0808

Fax: 65 6238 1108